Kampala Key, Vulnerable and Priority Populations (KVP) News

   Stop TB Partnership Statement On World AIDS Day - 2023 We Are Empowering TB Communities To Lead The Stop TB Partnership stands in solidarity with the families and friends of those who lost their lives to HIV-AIDS and TB-HIV co-infection and the communities and networks of people living with HIV and leading the response. 30 November 2023, Geneva, Switzerland - On this World AIDS Day we add our voice in calling for Communities to lead the responses at national and regional levels to end TB, HIV and Malaria as well as other diseases. TB is one of the leading causes of death in people living with HIV. As per the latest 2022 WHO data, 671,000 people living with HIV fell ill with TB, with the highest burden in countries in the WHO African Region, and TB caused 167,000 deaths in people living with HIV. The Stop TB Partnership stands in solidarity with the families and friends of those who lost their lives to HIV-AIDS and TB-HIV co-infection and the communities and networks of p...

Stop TB Partnership, USAID and the Global Fund negotiate landmark deal bringing down the price of a rapid molecular test for TB (Truenat) at US$ 7.90 per test   Geneva Switzerland –  Access to rapid molecular testing for TB is a right of people affected by TB. The Stop TB Partnership, United States Agency for International Development (USAID) and the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) announced a substantial price cut to the Truenat TB diagnostic test under a landmark agreement signed with Molbio Diagnostics, the maker of TB test Truenat.   Under the agreement, the price of the Truenat MTB and MTB Plus test will come down to US$ 7.90 per test from the current price of US$ 9. This will also include the supply of MTB-RIF Dx tests for subsequent testing for rifampicin resistance. Additionally, Molbio Diagnostics has agreed to provide timely service and maintenance of their diagnostic instruments.   The aim of the collabora...